Pretreatment neutrophil-to-lymphocyte ratio predicts treatment efficacy and prognosis of cytotoxic anticancer drugs, molecular targeted drugs, and immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

BACKGROUND: Neutrophil-to-lymphocyte ratio (NLR) has recently attracted attention as a prognostic predictor in patients with non-small cell lung cancer (NSCLC) who receive immune checkpoint inhibitors (ICIs). However, the utility of NLR in relation to cytotoxic anticancer drugs or molecular targeted...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishihara, Masashi, Ochiai, Ryosuke, Haruyama, Terunobu, Sakamoto, Takahiko, Tanzawa, Shigeru, Honda, Takeshi, Ota, Shuji, Ichikawa, Yasuko, Ishida, Tsuyoshi, Watanabe, Kiyotaka, Seki, Nobuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867774/
https://www.ncbi.nlm.nih.gov/pubmed/33569306
http://dx.doi.org/10.21037/tlcr-20-777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867774/
https://www.ncbi.nlm.nih.gov/pubmed/33569306
http://dx.doi.org/10.21037/tlcr-20-777

Ejemplares similares